Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders

Kannemeier Christian, Roemisch Juergen, Preissner Klaus T., Kanse Sandip
2003
OA: closed Metadata only

Abstract

Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/or treatment of vasoproliferative diseases and tumors.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-07T06:07:59.301721+00:00